Qinecsa Solutions (Qinecsa), a lead company in technology-driven end-to-end pharmacovigilance solutions has announced its acquisition of Insife ApS (Insife), a Danish-based firm specializing in innovative pharmacovigilance platforms.
An expert from the health tech company explains how AI, natural language processing, and other tools can improve pharmaceutical product safety reporting.
The company’s recent purchase by Drug Safety and Pharmacovigilance Services Solutions reportedly will fuel expansion of its Reportum PV platform technology.
A leader from the company discusses how advanced analytical tools can be put to work to help tackle adverse event case processing and compliance issues.
Leaders from ArisGlobal and Eversana explain the benefits of carefully selecting a research partner with a robust set of capabilities to see a project through.
The on-pack technology enables consumers, retailers and others to harness mobile devices in order to verify the authenticity of pharmaceutical products.
Fight the Fakes gathers manufacturers and other stakeholders to brainstorm on ways to combat falsified medicines and safeguard the world’s medicine supply.
BioIVT adds transporter assay products and services to its ADME-Toxicology portfolio with the acquisition of Optivia Biotechnology – a deal which aligns with the company’s efforts to support drug safety and efficacy, says VP.
WIRB Copernicus Group (WCG) has expanded its portfolio of companies to include the pharmacovigilance and drug safety solution provider Vigilare International.
Articles comparing CEO salaries are ten-a-penny at outsourcing publications these days as they use readily available data, are quick to compile and – to be frank – generate the strong web traffic that advertisers love.
Frank Torti has been appointed to the newly created post of chief
scientist at the FDA, with a brief to "oversee, coordinate, and
ensure quality and regulatory focus of the intramural research
programs".
China has announced an initial $1.7bn investment to bolster its
currently questionable ability to effectively monitor the quality
of the food and drugs manufactured within its borders.
The US Food and Drug Administration (FDA), under fire of late for
an alleged failure to properly ensure prescription drug safety, set
out its stall at last week's Food and Drug Law Institute meeting,
saying that it is increasingly...
US officials attempted to restore the reputation of the
pharmaceutical industry by announcing plans to introduce an
independent board, which aims to monitor the safety of drugs on the
market.
